Association of antibiotic utilization measures and control of extended-spectrum beta-lactamases (ESBLs) producing bacteria.
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Escherichia coli infections; Klebsiella infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 27 Dec 2007 The expected completion date for this trial is now 1 Jan 2008 according to ClinicalTrials.gov.
- 16 Jul 2007 New trial record.